307 related articles for article (PubMed ID: 36826704)
21. Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Knigge U; Dam G; Federspiel B; Grønbaek H; Stålberg P; Langer SW; Kjaer A; Arola J; Schalin-Jäntti C; Sundin A; Welin S; Thiis-Evensen E; Sorbye H
Acta Oncol; 2021 Jul; 60(7):931-941. PubMed ID: 33999752
[TBL] [Abstract][Full Text] [Related]
22. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
[TBL] [Abstract][Full Text] [Related]
23. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
24. Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
Sigel CS
Cancer Cytopathol; 2018 Dec; 126(12):980-991. PubMed ID: 30485690
[TBL] [Abstract][Full Text] [Related]
25. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.
Ptasnuka M; Ozolins A; Narbuts Z; Truskovs A; Sperga M; Plaudis H
World J Surg; 2020 Feb; 44(2):585-593. PubMed ID: 31605174
[TBL] [Abstract][Full Text] [Related]
26. Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions.
Detjen K; Hammerich L; Özdirik B; Demir M; Wiedenmann B; Tacke F; Jann H; Roderburg C
Neuroendocrinology; 2021; 111(3):217-236. PubMed ID: 32615560
[TBL] [Abstract][Full Text] [Related]
27. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms.
Saleh M; Bhosale PR; Yano M; Itani M; Elsayes AK; Halperin D; Bergsland EK; Morani AC
Abdom Radiol (NY); 2022 Sep; 47(9):3078-3100. PubMed ID: 33095312
[TBL] [Abstract][Full Text] [Related]
28. An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping.
Kawasaki K; Toshimitsu K; Matano M; Fujita M; Fujii M; Togasaki K; Ebisudani T; Shimokawa M; Takano A; Takahashi S; Ohta Y; Nanki K; Igarashi R; Ishimaru K; Ishida H; Sukawa Y; Sugimoto S; Saito Y; Maejima K; Sasagawa S; Lee H; Kim HG; Ha K; Hamamoto J; Fukunaga K; Maekawa A; Tanabe M; Ishihara S; Hamamoto Y; Yasuda H; Sekine S; Kudo A; Kitagawa Y; Kanai T; Nakagawa H; Sato T
Cell; 2020 Nov; 183(5):1420-1435.e21. PubMed ID: 33159857
[TBL] [Abstract][Full Text] [Related]
29. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
[TBL] [Abstract][Full Text] [Related]
30. Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
Festa S; Zerboni G; Derikx LAAP; Ribaldone DG; Dragoni G; Buskens C; van Dijkum EN; Pugliese D; Panzuto F; Krela-Kaźmierczak I; Mintz HR; Shitrit AB; Chaparro M; Gisbert JP; Kopylov U; Teich N; Vainer E; Nagtegaal I; Hoentjen F; Garcia MJ; Filip R; Foteinogiannopoulou K; Koutroubakis IE; Argollo M; van Wanrooij RLJ; Laja H; Lobaton T; Truyens M; Molnar T; Savarino E; Aratari A; Papi C; Goren I
J Crohns Colitis; 2022 Jul; 16(6):940-945. PubMed ID: 34864927
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database.
Panzuto F; Partelli S; Campana D; de Braud F; Spada F; Cives M; Tafuto S; Bertuzzi A; Gelsomino F; Bergamo F; Marcucci S; Mastrangelo L; Massironi S; Appetecchia M; Filice A; Badalamenti G; Bartolomei M; Amoroso V; Landoni L; Rodriquenz MG; Valente M; Colao A; Isidori A; Fanciulli G; Bollina R; Ciola M; Butturini G; Marconcini R; Arvat E; Cinieri S; Berardi R; Baldari S; Riccardi F; Spoto C; Giuffrida D; Gattuso D; Ferone D; Rinzivillo M; Bertani E; Versari A; Zerbi A; Lamberti G; Lauricella E; Pusceddu S; Fazio N; Dell'Unto E; Marini M; Falconi M
Endocrine; 2024 Apr; 84(1):42-47. PubMed ID: 38175391
[TBL] [Abstract][Full Text] [Related]
32. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
[TBL] [Abstract][Full Text] [Related]
33. Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system.
Wiedenmann B; John M; Ahnert-Hilger G; Riecken EO
J Mol Med (Berl); 1998 Aug; 76(9):637-47. PubMed ID: 9725766
[TBL] [Abstract][Full Text] [Related]
34. Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review.
Malla S; Kumar P; Madhusudhan KS
Abdom Radiol (NY); 2021 Mar; 46(3):919-935. PubMed ID: 32960304
[TBL] [Abstract][Full Text] [Related]
35. [Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].
Chen H; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):982-986. PubMed ID: 28900987
[TBL] [Abstract][Full Text] [Related]
36. SNM 2012 image of the year.
J Nucl Med; 2012 Oct; 53(10):23N. PubMed ID: 23028181
[No Abstract] [Full Text] [Related]
37. Quantitative 3D Assessment of
Adams LC; Bressem KK; Brangsch J; Reimann C; Nowak K; Brenner W; Makowski MR
J Nucl Med; 2020 Jul; 61(7):1021-1027. PubMed ID: 31862798
[No Abstract] [Full Text] [Related]
38. Treatment of Gastroenteropancreatic Neuroendocrine Tumors.
Perez K; Chan J
Surg Pathol Clin; 2019 Dec; 12(4):1045-1053. PubMed ID: 31672293
[TBL] [Abstract][Full Text] [Related]
39. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
[TBL] [Abstract][Full Text] [Related]
40. Under-Representation of Racial Groups in Genomics Studies of Gastroenteropancreatic Neuroendocrine Neoplasms.
Herring BR; Bonner A; Guenter RE; Vickers S; Yates C; Lee G; Dhall D; Chen H; Rose JB
Cancer Res Commun; 2022 Oct; 2(10):1162-1173. PubMed ID: 36969744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
